Table 3 Activity Sorafenib and Sunitynib in ChRCC
Agent | No. of patients | Median PFS (months) | Partial Response No. of patients | Stable Disease No. of patients |
|---|---|---|---|---|
Sunitinib | 7 | 8.9 | 1 | 6 |
Sorafenib | 5 | 27.5 | 2 | 3 |
Agent | No. of patients | Median PFS (months) | Partial Response No. of patients | Stable Disease No. of patients |
|---|---|---|---|---|
Sunitinib | 7 | 8.9 | 1 | 6 |
Sorafenib | 5 | 27.5 | 2 | 3 |